Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

LumiQuick Diagnostics

LumiQuick Diagnostics Inc. develops, manufactures and markets high quality point of care tests and other immunoassay ... read more Featured Products: More products

Download Mobile App





LumiQuick Diagnostics Showcases Rapid Tests Across Multiple Clinical Applications

By LabMedica International staff writers
Posted on 18 Nov 2026

LumiQuick Diagnostics (Santa Clara, CA, USA) is showcasing its portfolio of rapid diagnostic tests and immunoassay solutions at MEDICA 2026, taking place November 16–19 in Düsseldorf, Germany. More...

Exhibiting in Hall 3, Stand D25-4, the company is highlighting its capabilities across infectious disease testing, drugs-of-abuse screening, cardiac and tumor markers, fertility testing, and consumer self-testing. With more than two decades of experience in in vitro diagnostics (IVD), LumiQuick provides diagnostic products and manufacturing services to healthcare providers, laboratories, and distributors worldwide.

Among the company's key offerings is its QuickProfile rapid-test portfolio, designed for point-of-care and laboratory applications. The infectious disease range includes assays for malaria, dengue, Zika, chikungunya, influenza A/B, H. pylori, adenovirus, rotavirus, HIV, and syphilis. The portfolio also encompasses tests for cardiac markers, tumor markers, fertility hormones, and vitamin D, supporting a broad range of clinical diagnostic applications.

LumiQuick also offers an extensive drugs-of-abuse (DOA) testing portfolio, including single-test strips, single-drug cards, multi-drug panels, and multi-panel cups. The QuickProfile DOA range covers substances such as methamphetamine, cocaine, opiates, THC, fentanyl, and synthetic cannabinoids. These products provide different testing formats for drug screening applications in healthcare and laboratory settings.

The company's broader portfolio includes the Aoxre OxisResearch range, which provides assays for measuring oxidative stress biomarkers, antioxidants, DNA damage, and related indicators. These products support research into oxidative, nitrosative, and inflammatory processes associated with various medical conditions. In addition to its diagnostic products, LumiQuick offers original equipment manufacturing (OEM) and original design manufacturing (ODM) services, supporting partners in developing and marketing diagnostic solutions under their own brands.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Gold Member
Aspiration System
VACUSAFE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.